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Identifying molecular targets of Yersinia virulence
effectors, or Yops, during animal infection is chal-
lenging because few cells are targeted by Yops
in an infected organ, and isolating these sparse
effector-containing cells is difficult. YopH, a tyrosine
phosphatase, is essential for full virulence of Yersi-
nia. Investigating the YopH-targeted signal transduc-
tion pathway(s) in neutrophils during infection of a
murine host, we find that several host proteins,
including the essential signaling adaptor SLP-76,
are dephosphorylated in the presence of YopH in
neutrophils isolated from infected tissues. YopH in-
activated PRAM-1/SKAP-HOM and the SLP-76/
Vav/PLCg2 signal transduction axes, leading to an
inhibition of calcium response in isolated neutro-
phils. Consistent with a failure to mount a calcium
response, IL-10 production was reduced in neutro-
phils containing YopH from infected tissues. Finally,
a yopHmutant survived better in the absence of neu-
trophils, indicating that neutrophil inactivation by
YopH by targeting PRAM-1/SKAP-HOM and SLP-
76/Vav/PLCg2 signaling hubs may be critical for Yer-
sinia survival.
INTRODUCTION
Polymorphonuclear neutrophils (PMNs) migrate rapidly to in-
fected tissues, killing invading bacteria through a variety of
mechanisms, which include the production of reactive oxygen
intermediates (ROIs), phagocytosis, degranulation, and produc-
tion of neutrophil extracellular traps (NETs) (Nathan, 2006).
PMNs also secrete cytokines and chemokines, which modulate
additional immune responses either by activating resident im-
mune cells (Geijtenbeek and Gringhuis, 2009) or by suppressing
additional inflammation through secretion of IL-10 (Zhang et al.,
2009). One strategy bacterial pathogens use to counteract these
clearance mechanisms is through the direct delivery of effector
proteins into host cells by way of a type 3 secretion system306 Cell Host & Microbe 14, 306–317, September 11, 2013 ª2013 El(T3SS) (Viboud and Bliska, 2005). The Yersinia species are
predominantly extracellular bacteria that depend on their T3SS
for productive infection (Viboud and Bliska, 2005). All three Yer-
sinia species that are pathogenic in humans, Yersinia pseudotu-
berculosis (Yptb), Y. enterocolitica, and Y. pestis, target PMNs,
macrophages, and dendritic cells for translocation of their
effector proteins, called Yops (Durand et al., 2010; Ko¨berle
et al., 2009; Marketon et al., 2005). This suggests that Yops
are critical for inactivating PMNs in tissue infection and highlights
the importance of studying their functions in PMNs. Yop delivery
by the T3SS requires that Yersinia bind tightly to host cells (Gros-
dent et al., 2002). This tight association could render Yersinia
susceptible to capture and killing by PMNs through phagocy-
tosis and/or by NETs (Casutt-Meyer et al., 2010; Grosdent
et al., 2002). Collectively, Yops are presumed to block these
killing mechanisms and inactivate PMNs in tissue infection (An-
dersson et al., 1999; Grosdent et al., 2002; Spinner et al.,
2008); however, the precise mechanisms used to inactivate
PMNs in tissue infection are not known.
YopH, a tyrosine phosphatase, is critical for virulence of Yersi-
nia and has been studied extensively in a variety of cell culture
systems and in animal infection models (Black et al., 1998; Del-
euil et al., 2003; Logsdon and Mecsas, 2003; Persson et al.,
1997; Yuan et al., 2005). In isolated human PMNs, YopH inhibits
phagocytosis and calcium flux (Andersson et al., 1999; Grosdent
et al., 2002; Spinner et al., 2008), but it is not known which pro-
teins YopH targets to prevent these activities in PMNs. Twomain
classes of proteins, tyrosine kinases and their adapters, have
been identified as YopH substrates in various cell types. In
some cases, a substrate-trapping YopH mutant coprecipitates
with these substrates, suggesting that theymay be direct targets
of YopH (Black and Bliska, 1997; Black et al., 1998, 2000; Gerke
et al., 2005; Hamid et al., 1999); however, since many of these
proteins act in complexes, direct targets can be difficult to
discern. In epithelial cells, the adapters p130Cas and paxillin
(Black et al., 1998) interact with YopH. In macrophages, the
adapters ADAP, SKAP-HOM, and the tyrosine kinase FAK (Ha-
mid et al., 1999; Persson et al., 1997) associate with a substrate
trapping mutant. In T cells, the tyrosine kinases Lck and ZAP-70
and the adapters SLP-76 and LAT are dephosphorylated in the
presence of YopH (Alonso et al., 2004; Gerke et al., 2005).
Many of these YopH targets are found or have homologs in
PMNs and might be targets of YopH in PMNs during animalsevier Inc.
AB C
D E
Figure 1. PMN Depletion Restores Growth of a DyopH Strain in
Competition with WT
(A–E) BALB/c were infected i.v. with an equal mixture of WTKan and DyopH
after mock, 1A8, or RB68C5 injection and sacrificed 3 days p.i. (A) Percentage
of Gr1+CD11b+ cells in spleens of untreatedmice andmice treated with 1A8 or
RB68C5. Competitive indices (C.I.) in the (B) spleens and (D) livers of BALB/c-
depleted mice are shown. The total number of bacteria recovered in the (C)
spleen and (E) liver are shown. Each dot represents a mouse; horizontal bars
represent the average (A) or geometric mean (B–E); open circles indicate that
noDyopHwas recovered in 100 colonies tested. The experiment was repeated
twice and all the data are shown. C.I. = (DyopH / WTKan)output/(DyopH /
WTKan)input. Significance was calculated using one-way ANOVA followed by
Tukey’s post test (*p < 0.05 or **p < 0.01). See also Table S1.
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YopH Disables Signal Transduction in PMNsinfection. However, until recently it has been technically chal-
lenging to identify the molecular targets of Yops during animal
infection, because there were no good methods for isolating
the cells that contain effectors and the number of nontargeted
cells vastly exceeds the number of Yop-injected cells in an in-
fected organ. Thus, the effect of a Yop can be masked or diluted
when examining the whole population of a particular cell type
from an infected tissue. Using the TEM system (Durand et al.,
2010), we show that the PRAM-1/SKAP-HOM and SLP-76 signal
transduction pathway(s) are dephosphorylated in the presence
of YopH in PMNs, thus identifying a molecular target of a T3SS
effector in the context of animal infection.
RESULTS
Depletion of PMNs Permits Growth of a DyopH Mutant
during Coinfection with Wild-Type Yptb
Because YopH is critical for Yptb survival in the mouse (Bliska
et al., 1991; Logsdon and Mecsas, 2003) and PMNs are impor-
tant targets of Yop translocation (Durand et al., 2010; Ko¨berle
et al., 2009; Marketon et al., 2005), we hypothesized that YopHCell Host & Minactivates PMNs during Yptb infection. To test this hypothesis,
mice were depleted of PMNs with either antibody to Ly6G (1A8),
which depletes only PMNs, or antibody toGr-1 (RB6-8C5), which
depletes both PMNs and inflammatory monocytes (iMo) (Daley
et al., 2008). Mice were injected intravenously (i.v.) with an equal
mixture of WT Yptb and a DyopHmutant. Three days postinfec-
tion (p.i.), PMN levels in the spleen were reduced by 85%–99%,
as measured by FACS (Figure 1A). Strikingly, the DyopH strain
competed better in the spleen (Figure 1B) and liver (Figure 1C)
relative to theWT strain in the PMN-depletedmice than in control
mice. This suggests that YopH is critical for inactivating a spe-
cific bactericidal function of PMNs to enhance survival of Yptb.
The total number of bacteria in these organs were similar in
both groups of mice (Figures 1D and 1E), suggesting that at
this time point, Yptb efficiently disarms PMNs.
YopH Dephosphorylates Several Proteins in Splenic
PMNs
To understand how YopH inactivates PMNs in infected animals,
we investigated the molecular target(s) of YopH in PMNs during
animal infection. The TEM system can be used to identify and
isolate PMNs that contain Yops in an animal because TEMpos
cells also contain other Yops (Durand et al., 2010). An ETEM
gene fusion was introduced into WT and DyopH strains (Harmon
et al., 2010). Cells that are translocated with ETEM and incu-
bated with CCF4-AM fluoresce blue (TEMpos), whereas cells
lacking TEM and incubated with CCF4 fluoresce green (TEMneg).
Surface staining with cell type-specific antibodies allows for the
isolation of different types of cells within TEMpos and TEMneg
populations by FACS.
Mice were infected i.v. with 200 cfu WT-ETEM or 2,000 cfu
DyopH-ETEM so that equivalent numbers of Yptb were recov-
ered. Spleens were harvested and TEMposLy6G+ PMNs were
separated from TEMnegLy6G+ PMNs by FACS (Figure 2A). Day
5 was chosen because the greatest number of TEMpos cells
was recovered. Analysis of splenic PMN lysates by western
blot with a phosphotyrosine antibody revealed that at least five
proteins with molecular weights of 200 kDa, 160 kDa,
70 kDa, 55 kDa, and 35 kDa had decreased levels of phos-
phorylation in the presence of YopH compared to their levels of
phosphorylation in the absence of YopH (Figures 2B and 2C and
Figures S1A and S1B). This result suggests that YopH has mul-
tiple targets or that YopH dephosphorylates one protein in a
signal transduction pathway, which affects the phosphorylation
state of additional proteins in that pathway.
To determine if the spectrum of dephosphorylated bands
was similar in PMNs isolated from bone marrow (BMPMNs),
BMPMNswere infectedwithWT orDyopH for 30min atmultiplic-
ity of infection (moi) 50:1 (Figures 2D–2E and Figure S1C). Again
several proteins with molecular weights of160 kDa,120 kDa,
70 kDa, 55 kDa, and 35 kDa had reduced levels of phos-
phorylation after infection with WT compared to those BMPMNs
infected with DyopH (Figures 2D and 2E), suggesting that YopH
targetsmany of the same proteins in isolated BMPMNs as it does
in PMNs isolated from infected animals. More noticeable
dephosphorylation was observed in isolated BMPMNs versus
PMNs isolated from infected spleens, which is likely the result
of a more synchronous infection of BMPMNs and/or the fact
that BMPMNs were exposed to a greater moi of Yptb.icrobe 14, 306–317, September 11, 2013 ª2013 Elsevier Inc. 307
Figure 2. YopH-Dependent Dephosphorylation in PMNs Isolated from Spleens of Infected Animals
(A–E) Spleens frommice infected with WT-ETEM or DyopH-ETEM were harvested 5 days p.i., and TEMpos and TEMneg PMNs were collected (A–C). Western blot
analyses of 13 105 TEMpos PMNs and TEMneg PMNs probed with a a-phosphotyrosine antibody (4G10), stripped, and reprobed with a-actin antibody are shown
in (B) and (C). BMPMNs infected withWT orDyopH strains were lysed and probed with 4G10, stripped, and reprobed for actin (D and E). GeneTools software was
used to quantify the phosphorylation levels of bands of interest, denoted by *, by normalizing them to actin controls and then to TEMposDH lane (B–E). Each blot is
representative of at least two independent experiments. * and # denote bands with reduced intensities; ‘‘Un’’ denotes uninfected PMNs; see also Figure S1.
Cell Host & Microbe
YopH Disables Signal Transduction in PMNsSLP-76, but Not Paxillin, Is Dephosphorylated in the
Presence of YopH in PMNs from Infected Spleens
We first focused on testing whether the 70 kDa band, which
had a strong YopH-dependent dephosphorylation phenotype308 Cell Host & Microbe 14, 306–317, September 11, 2013 ª2013 Elin both conditions (Figures 2B–2E), represented one of the
known 70 kDa YopH targets, SLP-76 or paxillin (Black et al.,
1998; Gerke et al., 2005). In PMNs, SLP-76 (76 kDa) is involved
in signal transduction events important for activating ROSsevier Inc.
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Figure 3. SLP-76, but Not Paxillin, Is Dephosphorylated by YopH
during Animal Infection
(A) TEMpos PMNs and iMo (Gr1+CD11b+) frommice i.v. infectedwithWT-ETEM
orDyopH-ETEM for 5 days were collected by FACS. Lysates from 13 105 cells
were probed for total SLP-76 and phosphorylation at Y128.
(B) BMPMNs (53 105/lane) were infected with WT or DyopH for 5 min at a moi
of 50:1. Immunoprecipitated SLP-76 was analyzed by western blot for phos-
phorylated SLP-76 Y128, and total SLP-76.
(C and D) BMPMNs (C) or HEp-2 cells (D) were infected at moi 50:1 for 30 min
with WT or DyopH, lysed, and probed for phosphorylation at paxillin Y118 or
total paxillin. Blots shown are representative of at least two independent ex-
periments; see also Figure S2.
Cell Host & Microbe
YopH Disables Signal Transduction in PMNs(Newbrough et al., 2003), while paxillin (68 kDa) is involved in
actin dynamics leading to phagocytosis and cell movement
(Schaller, 2001). TEMpos Gr1+CD11b+ cells, which include both
PMNs and iMO, were isolated from mice infected for 5 days
with either WT-ETEM or DyopH-ETEM and analyzed by western
blot for SLP-76 phosphorylation at residue Y128. The level of
phospho-Y128-SLP-76 in mice infected with WT-ETEM wasCell Host & Mdrastically reduced compared to its level in mice infected with
DyopH-ETEM (Figure 3A). To confirm that phosphorylation of
SLP-76 was reduced in PMNs in the presence of YopH,
BMPMNs were infected with WT Yptb or DyopH for 5 min. Pro-
teins from BMPMN lysates were immunoprecipitated with
SLP-76 antibody, and the precipitated complexes were probed
with anti-SLP-76 phospho-Y128 (Figure 3B). Consistent with
our analysis of PMNs recovered from infected mice, SLP-76
was dephosphorylated in a YopH-dependent manner. Com-
bined, these results indicate that the SLP-76 signal transduction
pathway is targeted for dephosphorylation by YopH in PMNs
during mouse infection and in BMPMNs.
Next we tested whether paxillin was dephosphorylated in a
YopH-dependent manner in BMPMNs. No dephosphorylation
of paxillin Y-118 was observed in these cells regardless of
the presence or absence of YopH (Figure 3C). To confirm
that dephosphorylation of paxillin, a well-established target of
YopH in epithelial cells (Black et al., 1998), was detectable
with this antibody, HEp-2 cells were infected with either
WT-ETEM or DyopH-ETEM and analyzed by western blot
(Figure 3D). As expected, YopH-dependent dephosphory-
lation of paxillin was observed in HEp-2 cells, suggesting
that paxillin is not a major target of YopH in PMNs during
infection.
In PMNs, SKAP-HOM and PRAM-1, but Not Syk or ADAP,
Have Reduced Levels of Phosphorylation in the
Presence of YopH
SLP-76 is critical for transducing signaling events downstream
of both immunoreceptors and integrin receptors (Geijtenbeek
and Gringhuis, 2009; Newbrough et al., 2003). Therefore, we
investigated whether there was a YopH-dependent change in
phosphorylation status of proteins involved in transmitting
signals from either of these receptors upstream of SLP-76 (Fig-
ure S2). In PMNs, immunoreceptors transmit signals to SLP-76
through the adaptor protein, Syk (72 kDa) (Newbrough et al.,
2003). A homolog of Syk, ZAP-70, has reduced levels of phos-
phorylation in the presence of YopH in Jurkat T cells (Gerke
et al., 2005; Newbrough et al., 2003). To determine whether
Syk is targeted by YopH, TEMposGr1+CD11b+ and TEMnegGr1+
CD11b+ cells (both PMNs and iMOs) were harvested from
spleens of mice infected with either WT-ETEM or DyopH-
ETEM (4A). Western blot analysis revealed that the level of
phospho-Y352-Syk in TEMposGr1+CD11b+ cells infected with
WT-ETEM was comparable to its level in TEMposGr1+CD11b+
cells infected with DyopH-ETEM. This result suggests that the
Y352 residue of Syk is not a target of YopH in these cells. Phos-
phorylation of Syk at position Y352 leads to a conformational
change in the Syk kinase domain from a closed to an open
configuration (Kulathu et al., 2009). Syk then autophosphory-
lates the tyrosines in its activation loop at positions 525/526,
which results in recruitment of LAT and the propagation of
signaling through SLP-76 (Carsetti et al., 2009). Because we
observed stronger dephosphorylation signals in isolated
BMPMNs than in PMNs isolated from spleens after mouse
infection (Figure 2D), we assessed the phosphorylation state
of Syk in these cells following infection. Western blot analysis
of isolated BMPMNs infected with WT or DyopH for 5 or
30 min showed that the levels of phosphorylation at Y352 andicrobe 14, 306–317, September 11, 2013 ª2013 Elsevier Inc. 309
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Figure 4. YopH Dephosphorylates PRAM-1 and SKAP-HOM, but Not Syk or ADAP, in PMNs
(A)TEMpos Gr1+CD11b+ and TEMneg Gr1+CD11b+ PMNs and iMO from spleens of mice infected withWT-ETEM or DyopH-ETEM for 5 days were collected, lysed,
and probed for phosphorylation at Y352 in Syk or Rho-GDI as loading control.
(B) BMPMNswere infected for 5 or 30min at amoi of 50:1 with either WT orDyopH and thenwere lysed, resolved by SDS-PAGE, and analyzed by western blot for
phosphorylation of Syk pY352, Syk PY525/526, and total.
(C) J774 (53 105 cells/lane) and BMPMNs (23 106 cells/lane) were infected with WT or DyopH for 30min at a moi of 50:1. Lysates were immunoprecipitated with
antibodies to ADAP, resolved by SDS-PAGE, and analyzed by western blots for phosphotyrosine and total ADAP.
(D and E) BMPMNs (53 105 cells/lane) were infected with WT or DyopH for 30min at a moi of 50:1. Lysates were immunoprecipitated with antibodies to PRAM-1
(D) or SKAP-HOM (E), resolved by SDS-PAGE, and analyzed by western blot for phosphotyrosine and total PRAM-1 and SKAP-HOM. All blots shown are
representative of at least two independent experiments; see also Figure S3.
Cell Host & Microbe
YopH Disables Signal Transduction in PMNsY535/536 in Syk were not altered in the presence of YopH (Fig-
ure 4B). Combined, these results suggest that Syk is not a major
target of YopH in PMNs.
Next, we investigated whether proteins relaying signals from
integrin receptors were dephosphorylated in PMNs in the pres-
ence of YopH (Figure S2). ADAP (130 kDa) is a known target of
YopH in macrophages (Hamid et al., 1999) that signals down-
stream of integrin receptors. As the molecular weight of ADAP
is within the range of the120 kDa band that was dephosphory-
lated in the presence of YopH in BMPMNs (Figures 2D and 2E,
Figure S1C), we tested whether YopH dephosphorylates ADAP
in PMNs. BMPMNs were infected with WT Yptb or DyopH for
30 min. Proteins from lysates were immunoprecipitated
with ADAP antibodies, and the precipitated complexes were
analyzed by western blot with anti-phosphotyrosine antibody
(Figure 4C). Surprisingly, ADAP was not dephosphorylated in
BMPMNs, although as previously reported (Hamid et al., 1999),
ADAP was dephosphorylated in a YopH-dependent manner in
J774 cells (Figure 4C). Notably, the total levels of ADAP in
BMPMNs were lower when compared to its levels in other
lymphoid cell types, such as J774 macrophages and Jurkat
T cells (Figure S3). These results suggest that ADAP is not a
major target of YopH in PMNs or that it is only transiently de-
phosphorylated by YopH and not detected during the time
course of these experiments.310 Cell Host & Microbe 14, 306–317, September 11, 2013 ª2013 ElADAP has a homolog, PRAM-1 (100 kDa) that is highly
expressed in myeloid cells (Clemens et al., 2004), including
PMNs (Figure S3). PRAM-1 has been implicated in integrin
signaling in PMNs (Clemens et al., 2004) and interacts with
some of the same partners as does ADAP, including SLP-76
and SKAP-HOM (Moog-Lutz et al., 2001). To test whether
PRAM-1 was dephosphorylated in PMNs in a YopH-dependent
manner, PRAM-1 was immunoprecipitated from BMPMNs
infected with WT Yptb or DyopH, and the precipitated com-
plexes were analyzed by western blot with anti-phosphotyrosine
antibody (Figure 4D). In contrast to ADAP, PRAM-1 was dephos-
phorylated in a YopH-dependent manner in BMPMNs, suggest-
ing that YopH may directly target PRAM-1 and/or may target
another protein that relays signals from integrins through
PRAM-1 to SLP-76.
We next examined whether SKAP-HOM (55 kDa) was
dephosphorylated after infection with Yptb, because PRAM-1
associates with SKAP-HOM (Moog-Lutz et al., 2001), SKAP-
HOM has been identified as a YopH target in macrophages
(Black et al., 2000), and a band of approximately 55 kDa was de-
phosphorylated in a YopH-dependent manner in PMNs (Figures
2B–2E). Immunoprecipitation followed by western blot with anti-
phosphotyrosine antibody indicated that SKAP-HOM was de-
phosphorylated in a YopH-dependent manner (Figure 4E). In
summary, these results indicate that YopH can block signalssevier Inc.
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Figure 5. YopH Inactivates the SLP-76/Vav/PLCg2 Signaling Axis
and Prevents Calcium Flux in PMNs
(A) BMPMNs were infected for 5 or 30 min at a moi of 50:1 with either WT or
DyopH and then were lysed, resolved by SDS-PAGE, and analyzed by western
blot for phosphorylation of SLP-76 pY112, SLP-76 pY128, SLP-76 pY145,
Vav-1 pY174, phospho PLCg2, and total SLP-76. All data shown are repre-
sentative of at least two independent experiments.
Cell Host & Microbe
YopH Disables Signal Transduction in PMNs
Cell Host & Mdownstream of integrin receptors and prior to SLP-76 activation.
YopH may dephosphorylate multiple proteins, or the dephos-
phorylation of PRAM-1 and/or SKAP-HOM may result in the
low levels of phosphorylation of SLP-76.
YopH Targets the SLP-76/Vav/PLCg2 Signaling Axis and
Inhibits Calcium Flux in PMNs
Phosphorylation of SLP-76 occurs at three sites, Y112, Y128,
and Y145, and each phosphorylation site recruits and activates
sets of effectors that can then direct host responses (Jordan
and Koretzky, 2010). To identify the specific SLP-76 tyrosine res-
idue(s) that were not phosphorylated in the presence of YopH,
we infected BMPMNs for 5 or 30 min with WT or DyopH and
probed the cell lysateswith antibodies that specifically recognize
phosphorylated Y112, Y128, or Y145 in SLP-76. At 5 and 30 min
postinfection, SLP-76 tyrosine residues 112 and 128, but not
145, were dephosphorylated in a YopH-dependent manner (Fig-
ure 5A). Thus, YopH prevents high levels of phosphorylation at 2
of 3 sites in SLP-76, which should abrogate signal transduction
cascades downstream of SLP-76 in PMNs.
To investigate if YopH affects the activation of downstream
effectors of SLP-76, the phosphorylation states of Vav and
PLCg2 were examined in BMPMNs. Five minutes after infection
with DyopH-TEM, both Vav and PLCg2 were clearly phosphory-
lated, indicating that binding of Yptb stimulated their phosphor-
ylation (Figure 5A). However, neither was phosphorylated after
infection with WT-ETEM (Figure 5A). In PMNs the Vav/PLCg2
signaling cascade induces a release of intracellular calcium
within minutes after receptor stimulation and/or infection (Gra-
ham et al., 2007). Previous work has shown that YopH blocks
bacterial contact-induced immediate-early Ca2+ spikes in hu-
man PMNs (Andersson et al., 1999), although the mechanism
for this phenotype is not understood. To determine whether
the disruption of the Vav/PLCg2 pathway by YopH inhibited
calcium responses in murine PMNs, we measured the intra-
cellular calcium concentration of BMPMNs following infection
with Yptb. Ca2+ fluxes were observed in BMPMNs infected
with DyopH but not WT (Figure 5B), indicating that YopH is
required to block calcium fluxes in mouse PMNs. When
BMPMNs were exposed to U73122, an inhibitor of PLC, and
then infected with DyopH, no Ca2+ fluxes were observed, indi-
cating that activation of PLC was critical for the calcium flux trig-
gered by DyopH infection (Figure 5C). Calcium fluxes were
restored when BMPMNs were exposed to U73343, an U73122
analog that does not target PLC, and infected with DyopH (Fig-
ure 5C). Combined, these results suggest that the lack of phos-
phorylation at Y112 and Y128 at SLP-76 prevented activation
and phosphorylation of Vav and PLCg2, altering functions of
the SLP-76 complex such that it is unable to induce calcium
flux and mount subsequent bactericidal events.(B and C) BMPMNs were loaded with Fura-2 and (C) with 1 mMU73122 (a PLC
inhibitor) or with 1 mM of its inactive analog, U73343. After recording basal
levels for 2 (B) or 3 (C) min in a SpectraMaxM5 plate reader at 37C, cells were
infected (indicated by the arrow) with WT or DyopH strains at moi of 50:1 for
12 min, and then ionomycin (indicated by second arrow) was added. Fluo-
rescence was recorded over time to calculate intracellular calcium. Each
experiment was repeated three times, and a representative experiment is
shown.
icrobe 14, 306–317, September 11, 2013 ª2013 Elsevier Inc. 311
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Figure 6. YopH Inhibits IL-10 Secretion in PMNs
(A–C)Mice were infected i.v. with either WT-ETEM,DyopH-ETEM, orDyopE-ETEM for 5 days. TEMposLy6G+ (1A8) and TEMnegLy6G+ (1A8) PMNs from spleens of
each mouse were sorted by FACS (A). RNA was isolated and transcript levels of (B) IL-10 and (C) TNF-a were determined using real-time PCR. Each dot rep-
resents one animal.
(legend continued on next page)
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Cell Host & Microbe
YopH Disables Signal Transduction in PMNsYopH Inhibits IL-10 Production in PMNs during Infection
While many signaling events downstream of SLP-76, including
calcium flux, are transient and difficult to observe during animal
infections, cytokine production can be a longer-lasting conse-
quence of immune cell activation. In leukocytes, calcium flux
triggers activation of NF-AT, which in turn increases transcription
of IL-10 (Hogan et al., 2003; Lee et al., 2009). Because PMNs are
a major producer of IL-10 in infected tissues (Zhang et al., 2009),
we hypothesized that YopH would block transcription of IL-10 in
YopH-injected PMNs isolated from infected mice. mRNA from
TEMposLy6G+ PMNs of mice infected for 5 days with DyopH-
ETEM (Figures 6A and 6B) had significantly more IL-10 transcript
levels than TEMposLy6G+ cells containing YopH or than
TEMnegLy6G+ PMNs (Figure 6B). Moreover, intracellular IL-10
protein levels in TEMposGr1+CD11b+ PMNs and iMO isolated
from mice infected for 5 days with DyopH-ETEM were signifi-
cantly higher than TEMposGr1+CD11b+ cells from mice infected
with the WT-ETEM (Figure S4A). These results indicate that in
the absence of YopH, Yptb infection caused an increase in
IL-10 transcription and protein levels in injected PMNs. However,
translocated YopH blocked this response. TNF-a mRNA
and protein levels were elevated in TEMposLy6G+ cells infected
either with WT or DyopH (Figure 6C and Figure S4B), indicating
that YopH does not dampen all cytokine production at this
time point.
Since YopH prevents phagocytosis by PMNs (Grosdent et al.,
2002), it was possible that the increase in IL-10 in PMNs from
mice infected with DyopH-ETEM was due to a greater number
of TEMpos PMNs containing Yptb, which may trigger more IL-
10 production. To investigate this possibility, mice were infected
with a yopE mutant, DyopE-ETEM, which also prevents phago-
cytosis by PMNs (Grosdent et al., 2002). The levels of IL-10
mRNA in TEMpos PMNs isolated from DyopE-TEM-infected
mice were comparable to those found in PMNs from WT-
ETEM-infected mice and significantly lower than those found in
DyopH-ETEM-infected mice (Figure 6B). This result supports
the idea that YopH suppresses IL-10 expression in PMNs.
Next, the levels of phagocytosed WT, DyopH, or DyopEmutants
were assessed using a gentamicin protection assay on single-
cell suspensions of spleens from infected mice. Equivalent
numbers of WT, DyopH-ETEM, and DyopE-ETEM were recov-
ered from spleens and were protected from gentamicin (Figures
S4C and S4D). Thus, either all strains were internalized at the
same efficiency or the mutants were internalized at higher levels
but did not survive. Finally, we determined whether the internal-
ized viable WT Yptb were detected in TEMpos or TEMneg cells. In
5 of 7mice, no Yptbwere recovered in TEMpos cells while low but
detectable levels were recovered in TEMneg cells (Figures S4E
and S4F). Since the number of TEMneg cells vastly exceeds the
number of TEMpos cells, and we collected the majority of TEMpos
cells, most viable Yptb resided within TEMneg cells. The finding
that TEMpos cells do not contain live Yptb suggests that differ-
ences between TEMpos cells from mice infected with different
mutants are likely due to the specific effectors within these cells.(D and E) BMPMNswere untreated or pretreated with 25 mMBAPTA for 30min and
before gentamicin was added. The supernatants were collected 12 hr after the a
independent experiments were performed in triplicate. The average ± SEM of on
using one-way ANOVA with Tukey’s post test. * indicates p < 0.05; see also Figu
Cell Host & MTo confirm that calcium flux is critical for IL-10 production in
PMNs during Yptb infection, chemicals that block calcium flux,
BAPTA-AM, 2-APB, or EGTA, were added to BMPMNs.
BMPMNs were then infected with Yptb strains lacking five
effector Yops, D5, or D5 strains in which YopH or YopE were
expressed from an arabinose-inducible promoter. Supernatants
were collected and IL-10 levels were determined (Figure 6D and
Figure S4G). In the absence of calcium flux inhibitors, signifi-
cantly higher levels of IL-10 were detected in supernatants of
BMPMNs infected with D5 and D5 + pYopE compared to D5 +
pYopH, confirming that the presence of YopH is sufficient to
block IL-10 production after D5 infection. When calcium flux
was blocked, IL-10 levels produced byD5 andD5 + pYopE drop-
ped to the similar levels as those found in uninfected controls
and D5 + pYopH infected cells, indicating that calcium flux
was required for IL-10 production. LDH release was measured
to determine if IL-10 release was either due to or blocked by
cell death of BMPMNs (Figure 6E and Figure S4H). While the
level of LDH release increased after exposure to BAPTA, impor-
tantly, the levels were the same in uninfected, D5, and D5 +
pYopH infected BMPMNs. This result suggests that the differ-
ences in IL-10 levels from these cells were not due to differences
in cell death. Infection with D5 + pYopE regardless of the pres-
ence of calcium flux inhibitors stimulated LDH release, indicating
that YopE causes PMN cell death. However, since IL-10 was
only detected in the supernatant in the absence of calcium flux
inhibitors, this is again consistent with the idea that D5 infection
stimulates IL-10 production when cells can flux calcium and
YopE does not suppress IL-10 production. Collectively, these re-
sults demonstrate that YopH inhibits calcium flux and prevents
IL-10 production in PMNs.
DISCUSSION
The functions of T3SS effectors have been studied extensively in
cell culture models (Alonso et al., 2004; Black et al., 1998, 2000;
Deleuil et al., 2003; Gerke et al., 2005; Hamid et al., 1999; Yuan
et al., 2005). While informative, these cell culture models do not
fully recapitulate the interactions between Yptb and host cells
during infection, because cell culture models seldom involve
the full array of cells and their activation states that occur in tis-
sues. However, until recently it has been technically difficult to
identify themolecular targets of the T3SS effectors during animal
infection because there were no good methods for isolating the
cells containing effectors. Here we demonstrate a specific signal
transduction pathway targeted by a T3SS effector during animal
infection and show that the adapters, PRAM-1, SKAP-HOM, and
SLP-76, are dephosphorylated in the presence of YopH in
PMNs.
This approach is broadly applicable to the study of effectors in
animal model systems from pathogens that use T3SS, T4SS, or
T6SS. Furthermore, both global and focused strategies can be
used to uncover the consequences to host cells after injection
with different effectors using this system. For instance, effectorsthen infected withD5 + pBAD,D5 + pYopH, orD5 + pYopE at moi 10:1 for 4 hr
ddition of gentamicin and IL-10 (D) and LDH (E) levels were determined. Three
e representative experiment is shown. Statistical significance was calculated
re S4.
icrobe 14, 306–317, September 11, 2013 ª2013 Elsevier Inc. 313
Figure 7. Model of YopH Targets in PMNs
YopH targets SLP-76 and/or PRAM-1/SKAP-HOM
signal transduction pathways in PMNs. White
shapes represent direct or indirect targets of
YopH. Calcium flux is blocked and cytokine pro-
duction altered. Syk, ADAP, and paxillin (hatched
shapes) were tested, but were not dephosphory-
lated by YopH in PMNs. Gray shapes represent
molecules in pathway not tested.
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YopH Disables Signal Transduction in PMNsfrom a number of bacterial pathogens, including YopJ from Yer-
sinia, target MAPK and NF-kB pathways (Krachler et al., 2011).
To discern their roles in cells from infected tissues, one could
examine ubiquitination or phosphorylation patterns of putative
targets; monitor proinflammatory responses at either the tran-
scriptional or posttranscriptional level, as we have done; and/
or evaluate expression of cell surface proteins to assess cell acti-
vation states. Global approaches, such as RNA-seq, to profile
cells injected with different effectors are also very feasible.
Finally, when cells are long-lived, the ability of injected cells to
perform various functions, such as presenting antigens, could
be studied after their isolation. These studies are limited by the
number of injected cells recovered, the sensitivity of reagents
available to probe for changes, and whether changes within cells
are transient or long-lasting. For example, in our case about
2–4 3 104 TEMpos PMNs were recovered in each spleen. There-
fore, we pooled PMNs from several mice for western blot anal-
ysis and measurement of cytokine protein levels. Despite these
constraints, this approach is a significant and powerful step
forward in our ability to probe the roles of effectors in animal
infection, as it permits scrutiny of effector functions in cells
from infected tissues.
The dephosphorylation patterns due to YopH from PMNs iso-
lated from infected mice compared to infected BMPMNs were
similar but not identical. Differences could result from the fact
that BMPMN infection was synchronized so that proteins that
are transiently dephosphorylated were detected. In addition,
recently migrated PMNs from infected spleensmay be in different
activation states than BMPMNs and therefore may be expressing
different proteins that are susceptible to YopH. Our prior knowl-
edge of YopH targets greatly facilitated the identification of SLP-
76. In the absence of such knowledge, the bands could have
been identified by infecting mice with a substrate-trapping, cata-
lytically inactive form of YopH, YopHC403A (Black et al., 2000),
followed by coimmunoprecipitation with antibody to YopH and
either western blotting with antibody to putative targets or mass314 Cell Host & Microbe 14, 306–317, September 11, 2013 ª2013 Elsevier Inc.spectrometry analysis. While we have not
definitively identified the 55 kDa de-
tected in PMNs isolated from infected
spleens, we think it is SKAP-HOM based
on our finding that SKAP-HOM was de-
phosphorylated inBMPMNs.Wehypothe-
size that the 160 kDa bandmay be PLCg2
(147 kDa) or a DOCK; the 120 kDa band
may be Vav (98 kDa), PRAM-1 (100 kDa),
CASL (120 kDa), Pyk2 (120 kDa), or FAK
(130 kDa); and the200 kDaprotein could
be a DOCK.The steps required for signaling downstream of integrin and
immunoreceptor engagement have been studied far less inten-
sively in PMNs than in B and T cells (Figure S2) (Jordan and Ko-
retzky, 2010; Newbrough et al., 2003). Nonetheless, many of the
same proteins or their homologs relay signals from receptors to
mount PMN-specific responses to pathogens (Brinkmann et al.,
2004; Newbrough et al., 2003). Our findings that SKAP-HOM,
PRAM-1, SLP-76, PLCg2, and Vav1 are all dephosphorylated
in the presence of YopH could result from one of several sce-
narios (Figure 7). YopH could target each of these proteins; how-
ever, we think this is unlikely because phosphorylation levels of
PLCg2 and Vav are restored in BMPMNs after 30 min, yet
YopH is still present. Alternatively, YopH could target only one
or a subset of proteins in this pathway and thereby disrupt all
subsequent phosphorylation events. Either is consistent with
our data because SLP-76 and SKAP-HOM complexes are two
major signal transduction hubs that relay information to each
other and participate in inside-out and outside-in signaling in
other cells (Figure 7 and Figure S2) (Alenghat et al., 2012; Me´na-
sche´ et al., 2007; Togni et al., 2005). While to date there have
been no studies on SKAP-HOM in PMNs, PRAM-1 regulates
several integrin-dependent functions, including ROI production
and degranulation (Clemens et al., 2004). Likewise, phosphoryla-
tion of SLP-76 is critical for integrin-dependent PMN spreading,
degranulation, and ROI production (Jordan and Koretzky, 2010).
These effects are consistent with previously described pheno-
types of YopH in PMNs. Specifically, YopH has been shown to
block phagocytosis, calcium fluxes, and ROI production in hu-
man PMNs (Andersson et al., 1999; Grosdent et al., 2002; Ruck-
deschel et al., 1996). Combined, these data indicate that YopH
disarms bactericidal effects of PMNs in infected tissues by tar-
geting SLP-76 and/or SKAP-HOM/PRAM-1, thereby blocking
phagocytosis, calcium signaling, and ROI production.
The observation that YopH reduced IL-10 production in PMNs
from infected spleens supports the conclusion that YopH inter-
feres with SLP-76 and PLCg2 activation because activation of
Cell Host & Microbe
YopH Disables Signal Transduction in PMNsPLCg2 induces calcium flux activating NF-AT, which drives IL-10
expression (Hogan et al., 2003; Lee et al., 2009). IL-10 produc-
tion after Yptb infection has been previously studied in BMDM
and in tissues and serum of infected mice (Auerbuch and Isberg,
2007; McPhee et al., 2012). Consistent with our results, Auer-
buch and Isberg found that IL-10 was more strongly induced in
Yptb-infected BMDM in the absence of the T3SS, suggesting
that one or more Yops suppress its expression. However,
McPhee et al., found that IL-10 levels were elevated in sera of
mice infected with YopM-expressing strains (McPhee et al.,
2012). Furthermore, this YopM-dependent induction of IL-10 is
likely critical for Yptb infection, because growth of yopM was
partially restored in the absence of IL-10 or when IL-10 was sup-
plied exogenously. These apparent discrepancies could be due
to differences in bacterial strains and/or tissue samples used in
these studies and require further study. Downregulation of IL-
10 by YopH in PMNs may be an unintended consequence of
other, more proximal SLP-76-regulated events disrupted by
YopH. Alternatively, Yptb may thrive best in environments
when low levels of IL-10 are produced by PMNs, but higher
levels emanate from other cell types.
In conclusion, the findings that PMNs are selectively targeted
for Yop translocation (Durand et al., 2010) and that PMNs are re-
cruited to the site of Yptb infection (Crimmins et al., 2012) sug-
gested that the function of Yops in PMNs is critical for successful
colonization. We found that YopH targets the PRAM-1/SKAP-
HOM and SLP-76 signal transduction pathways in PMNs. How-
ever, because growth of DyopH was not fully restored in the
absence of PMNs, we propose that YopH has additional func-
tions in other cell types that promote Yptb survival. Future
work is directed at determining all the targets of YopH in PMNs
and understanding how the SKAP-HOM/PRAM-1 and SLP-76
pathways collaborate in PMNs.EXPERIMENTAL PROCEDURES
Bacterial Strains and Mouse Infections
Strains and plasmids used in this work are listed in Table S1. For mouse infec-
tions, strains were grown as described in Logsdon and Mecsas, 2003. For
infection of BMPMNs, J774 macrophages, or HEp-2 cells, strains were grown
in Yop-inducing conditions in 2xYT + 20mM sodium oxalate and 20mMMgCl2
for 2 hr at 26C, shifted to 37C for 2 hr, and then used to infect cells at a moi of
50:1 for 5 or 30 min. Strains carrying pBAD plasmids were exposed to 50 mM
arabinose prior to the shift to 37C and throughout the infection.
Female BALB/c mice (6–8 weeks old) obtained from NCI were challenged
i.v. with 200 cfu of WT-ETEM, 2,000 cfu of DyopH-ETEM, or 1,000 cfu of
DyopE-ETEM for 5 days except for cell depletion experiments. Different doses
were used so that comparable numbers of bacteria and TEMpos cells were
recovered. For cell depletions, mice were intraperitoneally injected with
50 mg of the Ly6G (1A8) antibody, which depletes PMNs, or the Gr1 (RB6-
8C5) antibody, which depletes PMNs, and iMO 1 day prior to and 2 days after
i.v. inoculation with an equal mixture of kanamycin-resistant IP2666 WT and
DyopH (1,000 total bacteria). Tissues were harvested 3 days p.i. Depletion
with RB6-8C5 results in low levels of PMNs as detected by blood smears
and FACS with RB6-8C5 (unpublished data).
Experiments involving animals were performed with approval of The Institu-
tional Animal Care and Use Committee of Tufts University.
PMN Sorting, CCF4-AM Conversion Assays, and Western Blots
Single-cell suspensions of splenocytes from infected mice were generated
and labeled as described (Durand et al., 2010) and incubated for 30 min in
the dark at room temperature in media containing 1 mg/ml CCF4-AMCell Host & M(Invitrogen), 1.5 mM probenecid (Sigma), and 100 mg/ml gentamicin for
30 min at 4C with PECy5-CD11b (eBioscience) and PECy7-Ly6G (1A8) (BD
PharMingen) to isolate PMNs (Ly6G+). In experiments described in Figure 3A,
Figure 4A, and Figures S4A and S4B, PE-Cy5Gr1+, PE-Cy7CD11b+ spleno-
cytes were collected, which contained a 5:1 ratio of PMNs to iMO. Between
2 and 43 104 TEMpos and TEMneg PMNswere collected permouse. Cells were
pooled so that13 105 TEMpos and TEMneg PMNs were analyzed by western
blot. TEMneg PMNs from uninfected mice were collected as controls.
Cells were lysed in SDS sample buffer and 1 3 105 cell equivalents were
resolved on a 10% SDS-PAGE gel and electrotransferred to Immobilon-P for
western blot analysis with the following primary antibodies: anti-phosphotyro-
sine (4G10, Millipore), phospho-paxillin Y118, paxillin, SLP-76, phospho-Zap-
70 Y319/Syk Y352, phospho-Syk Y525/526 (Cell Signaling), phospho-SLP-76
(Y112, Y128 or Y145) (BD PharMingen), phosphor-Vav Y174 (Abcam), SKAP-
HOM (Protein Tech), PRAM-1 (Santa Cruz), anti-mouse IgG-HRP-conjugated,
and anti-rabbit IgG-HRP-conjugated.
Western Blot Quantification
Western blot quantifications were analyzed with Gene Tools from Syngene
software as follows. For profile heights, the software scanned down individual
lanes (higher to lower molecular weight), assigned Rf values to each detected
band, and represented them as histograms (height/area of the band versus Rf
value down the lane). The level of phosphorylation for each band is repre-
sented as the area under the peak. Lanes were compared by overlapping
the histogram graphs. Bands with similar phosphorylation levels will overlap,
i.e., their peak height and area will be similar, while bands with different phos-
phorylation levels will have different areas under their respective curves.
BMPMN Isolation
BMPMNs were isolated using a Percoll gradient as follows. RPMI was forced
through both femur and tibia bones with a syringe, and the solution was
passed through a 70 mm cell strainer. Cells were pelleted; erythrocytes were
lysed, resuspended in 1 ml HBSS without calcium or magnesium, applied to
a three-step gradient of 55%, 65%, and 75% Percoll, and centrifuged at
300 3 g for 30 min at room temperature without brakes. Cells at the 65%–
75% interface were collected and washed with HBSS. PMN purity was more
than 95% according to flow cytometry analysis with PECy7-Ly6G antibody.
Immunoprecipitations
Either 5 3 105 or 2 3 106 cells were infected for 5 min (SLP-76) or 30 min
(ADAP, PRAM-1, or SKAP-HOM)withWT Yptb orDyopH at amoi of 50:1. Cells
were washed with PBS and then lysed in 200 ml ice-cold immunoprecipitation
buffer (50 mM Tris-HCl [pH 7.4], 1% NP-40, 1 mM EGTA, 150 mM NaCl, 1 mM
Na3VO4, 10 mM NaF, and Complete Protease inhibitor [Sigma]) for 30 min at
4C. Lysates were centrifuged at 13,000 3 g for 10 min. Supernatants were
incubated for 16 hr at 4C with 2 mg antibody coupled with protein G-Sephar-
ose beads. Beads were collected by a brief centrifugation and washed three
times with immunoprecipitation buffer. Immune complexes were heated to
95C in SDS-PAGE sample buffer for 5 min and subjected to western blot
analysis.
Intracellular Ca2+ Measurements
A total of 2 3 105 cells (BMPMNs) were loaded with 4 mM Fura-2 in 96-well
plates and placed at 37C in a SpectraMax M5 plate reader (Molecular De-
vices). Fluorescence at 340 and 380 nm was recorded every 20 s. Basal levels
were recorded for 2–3 min, PMNs were infected with WT or DyopH at a moi of
50:1 for 12 min, and then ionomycin was added to each well. For experiments
with the phospholipase inhibitor, 1 mM of U73122, or its inactive analog,
U73343, were preincubated with BMPMNs for 3 min, prior to addition of
Yptb. Intracellular calcium concentrations were calculated as described in
Grynkiewicz et al., 1985.
IL-10 ELISA Measurements and LDH Released
Calcium flux inhibitors or chelators (25 mM BAPTA-AM, 50 mM 2-APB, or 5 mM
EGTA) were added 30 min before infection. BMPMNs (83 104 cells/well) were
infected with D5 + pBAD, D5 + pYopH, or D5 + pYopE at moi of 10:1 for 4 hr.
Gentamicin (100 mg/ml) was added for 12 hr before supernatants were
collected. IL-10 and LDH levels were determined using the Mouse IL-10 ELISAicrobe 14, 306–317, September 11, 2013 ª2013 Elsevier Inc. 315
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YopH Disables Signal Transduction in PMNsReady-SET-Go Kit (eBioscience) or CytoTox 96 Non-Reactive Cytotoxicity Kit
(Promega), respectively.
Real-Time PCR
Five days p.i. with WT-ETEM, DyopH-ETEM, or DyopE-ETEM, splenocytes
were collected, loaded with CCF4-AM, and labeled with CCF4 and PECy7-
Ly6G (1A8) to sort TEMpos Ly6G+ and TEMneg Ly6G+. RNA was isolated using
Tri-Reagent according to the manufacturer’s instructions. One microgram of
RNA was transcribed to cDNA using TaqMan Reverse Transcription Reagents
(Applied Biosystems). cDNA was amplified with primer sets (Overbergh et al.,
2003) for mouse IL-10, TNF-a, and GAPDH using SYBR PCR master mix
(Applied Biosystems) and an ABI PRISM 7900HT detection system according
to the manufacturer’s instructions. Fold induction of mRNA was determined
from the threshold cycle (Ct) values normalized for GADPH expression and
to the value derived from the naive controls.
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